There Are Currently 165 Therapeutics Targeting Pancreatic Cancer, From Early Preclinical To Marketed Drugs
Posted on: Monday, 27 August 2007, 09:13 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c66736) has announced the addition of "Pancreatic Cancer Drug Pipeline Update 2007" to their offering.
There are today more than 165 therapeutics targeting pancreatic cancer, from early preclinical to marketed drugs. Pancreatic Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 110 different targets. These targets are further categorized on the CD-ROM by 37 classifications of molecular function and their possible belonging to 19 different signaling pathways in the cell. Read more below on how the Pancreatic Cancer Drug Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
Find competitors, collaborations partners, M&A candidates etc.
Jump start competitive drug intelligence operations
Excellent starting point for world wide benchmarking
Compare portfolio and therapy focus with your peers
Speed up pro-active in-/out licensing strategy work
Fast and easy way of tracking drugs using search engines; just one click and you may search the World Wide Web and PubMed for any drug.
Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.
Drug Pipeline Update at a Glance
Investigators Includes more than 135 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators.
Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator.
Drug name & Synonyms Lists commercial, generic and code names for drugs. In all more than 700 names
Developmental stage This Drug Pipeline Update contains more than 165 drugs in active development for the treatment of pancreatic cancer:
10 marketed drugs
15 drugs in Phase III
> 60 drugs in Phase II
> 45 drugs in Phase I
> 30 drugs in Preclinical
Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application.
Indications Included pancreatic cancer drugs are also in development for over 90 other indications.
Note: You are able to sort and find drugs according to type of indication from drop-down menu in the application.
Targets Identified drugs are linked to 110 different targets, divided into 37classifications of molecular function:
Carboxy-lyase activity
Catalytic activity
Cell adhesion molecule activity
Cysteine-type peptidase activity
Cytokine activity
DNA repair protein
DNA topoisomerase activity
DNA-directed DNA polymerase activity
Extracellular matrix structural constituent
G-protein coupled receptor activity
Growth factor activity
Hormone activity
Hydrolase activity
Kinase activity
Ligand-dependent nuclear receptor activity
Ligase activity
Lipase activity
Lipid phosphatase activity
Molecular function unknown
Oxidoreductase activity
Protein binding
Protein serine/threonine kinase activity
Protein threonine/tyrosine kinase activity
Protein-tyrosine kinase activity
Receptor activity
Receptor binding
Receptor signaling complex scaffold activity
RNA-directed DNA polymerase activity
Serine-type peptidase activity
Structural constituent of cytoskeleton
T cell receptor activity
Transcription factor activity
Transcription regulator activity
Translation regulator activity
Transmembrane receptor protein tyrosine kinase activity
Transporter activity
Unclassified
Identified targets are categorized into 18 different primary and alternate localizations:
Centrosome
Clathrin-coated vesicle
Cytoplasm
Cytoskeleton
Cytosol
Endoplasmic reticulum
Endosome
Extracellular
Golgi apparatus
Integral to membrane
Lysosome
Mitochondrial membrane
Mitochondrion
Nucleolus
Nucleus
Plasma membrane
Secreted
Secretory granule
Note: You are able to sort and find drugs according to target name, molecular function of target, and target localization from drop-down menus in the application.
For more information visit http://www.researchandmarkets.com/reports/c66736
Source: Business Wire
Related Articles
- First Pediatric Patient Treated With Aptocine(TM), a Novel Light-Activated Drug, in Neurofibromatosis Study
- Renal Cancer Drug Pipeline Update Lists All Drugs and Gives You a Progress Analysis on Each One of Them
- The Colorectal Drug Pipeline Update 2007 Lists All Drugs and Gives You a Progress Analysis on Each One
- Hematological Cancers Drug Pipeline Update 2006 Lists More Than 230 Drugs and Gives You a Progress Analysis on Each One of Them
- Lung Cancer Drug Pipeline Update Lists All 243 Drugs for Lung Cancer and Gives You a Progress Analysis on Each One of Them
- Today, There Are More Than 100 Companies Developing More Than 180 Protein Kinase Inhibitory Drugs in More Than 300 Clinical Trials Targeting Around 40 Different Cancer Indications
- Proteins Show Promise As Cancer Treatment Tool; Proteomics Also Could Help Guide Cancer Drug Development, Study Finds
- Drug Shows Promise on Prostate Cancer
- Drugs Found In Nature Stop Cancer Spread
- Trial Drugs Offer Hope for Brain Cancer
User Comments (0)

RSS Feeds